M1

VRT106 · Guangzhou Virotech Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M1, covering 2025-12-30 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors [Phase 1]